Long non‐coding RNA FOXD1‐AS1 modulated CTCs epithelial‐mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging miR ‐615‐3p
Cancer Reports · 2024
DOI: 10.1002/cnr2.2050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Bao-Ling Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Longyan City Science and Technology Plan Project.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is widely recognized as a globally prevalent malignancy. Immunotherapy is a promising therapy for HCC patients. Increasing evidence suggests that lncRNAs are involved in HCC progression and immunotherapy.
Aim
The study reveals the mechanistic role of long non‐coding RNA (lncRNA) FOXD1‐AS1 in regulating migration, invasion, circulating tumor cells (CTCs), epithelial‐mesenchymal transition (EMT), and immune escape in HCC in vitro.
Methods
This study employed real‐time PCR (RT‐qPCR) to measure FOXD1‐AS1 , miR‐615‐3p, and programmed death‐ligand 1 ( PD‐L1 ). The interactions of FOXD1‐AS1 , miR‐615‐3p, and PD‐L1 were validated via dual‐luciferase reporter gene and ribonucleoprotein immunoprecipitation (RIP) assay. In vivo experimentation involves BALB/c mice and BALB/c nude mice to investigate the impact of HCC metastasis.
Results
The upregulation of lncRNA FOXD1‐AS1 in malignant tissues significantly correlates with poor prognosis. The investigation was implemented on the impact of lncRNA FOXD1‐AS1 on the migratory, invasive, and EMT of HCC cells. It has been observed that the lncRNA FOXD1‐AS1 significantly influences the generation and metastasis of M CTC in vivo analysis. In mechanistic analysis, lncRNA FOXD1‐AS1 enhanced immune escape in HCC via upregulation of PD‐L1 , which acted as a ceRNA by sequestering miR‐615‐3p. Additionally, lncRNA FOXD1‐AS1 was found to modulate the EMT of CTCs through the activation of the PI3K/AKT pathway.
Conclusion
This study presents compelling evidence supporting the role of lncRNA FOXD1‐AS1 as a miRNA sponge that sequesters miR‐655‐3p and protects PD‐L1 from suppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, People's Republic of China.
ORCID-Profile: Zhi-Yong Chen
Förderung
- Longyan City Science and Technology Plan Project
Zitieren
APA
Guo, B. L., Zheng, Q. X., Jiang, Y. S., Zhan, Y., Huang, W. J., & Chen, Z. Y. (2024). Long non‐coding RNA FOXD1‐AS1 modulated CTCs epithelial‐mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging miR ‐615‐3p. Cancer Reports. https://doi.org/10.1002/cnr2.2050
Vancouver
Guo BL, Zheng QX, Jiang YS, Zhan Y, Huang WJ, Chen ZY. Long non‐coding RNA FOXD1‐AS1 modulated CTCs epithelial‐mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging miR ‐615‐3p. Cancer Reports. 2024. doi:10.1002/cnr2.2050
BibTeX
@article{Guo2024,
author = {Guo, Bao-Ling and Zheng, Qiu-Xiang and Jiang, Yun-Shan and Zhan, Ying and Huang, Wen-Jin and Chen, Zhi-Yong},
title = {Long non‐coding RNA FOXD1‐AS1 modulated CTCs epithelial‐mesenchymal transition and immune escape in hepatocellular carcinoma in vitro by sponging miR ‐615‐3p},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.2050}
}
EUVIMED